Novartis
Sloveniacompany5.0Global Dominance: 0.00%Novartis is a Swiss multinational pharmaceutical company known for its innovative medicines and commitment to research and development. It has a strong presence in the global healthcare market and has been recognized for its contributions to various therapeutic areas, including oncology and cardiovascular health.
Country presence
Recent news mentions
Novartis is not included in the ranking as data about its operations is not yet available.
Katera slovenska podjetja imajo največ dobičkaSlovenia· 2026-06-19
Novartis is another important pharmaceutical manufacturer in Switzerland that needs to stay out of Trump's trade conflicts.
Die Schweiz exportiert mehr denn je in die USA
Switzerland· 2026-01-29
Novartis is another major pharmaceutical company planning to increase production in the USA.
Trump und die Schweiz: Den Handelsbilanzüberschuss interaktiv senkenSwitzerland· 2026-01-16
Novartis is another Swiss pharmaceutical company that has announced plans to invest in the U.S.
Trump schliesst Deals mit PharmafirmenSwitzerland· 2025-12-19Novartis has announced investments of 50 billion dollars in the USA for new production capacities.
Kann die Schweiz das Handelsbilanzdefizit eliminieren?Switzerland· 2025-12-16
Swiss pharmaceutical giant Novartis has promised to largely shift production for the American market to the USA.
BIP schrumpft wegen Trumps Zöllen im dritten QuartalSwitzerland· 2025-11-17The government and the laboratory Novartis were refining the conditions of a long renegotiation.
El "acuerdo histórico" del Gobierno por uno de los remedios más caros del mundo y lo que no se contó
Argentina· 2025-09-16
Novartis is mentioned as a foreign investor contributing to the development of the pharmaceutical sector in Slovenia.
Koristen korak, a nujni sistemski ukrepiSlovenia· 2025-08-20
Novartis is mentioned as a pharmaceutical company that has begun considering production relocation to the USA.
warum Schweizer Firmen ihn nicht voll auf US-Preise schlagen könnenSwitzerland· 2025-08-13
Novartis has expressed intentions to expand its production in the USA.
Bei den Medikamentenpreisen hat Trump die Zahlen auf seiner SeiteSwitzerland· 2025-08-12
Novartis is another major pharmaceutical company based in Switzerland.
Die Schweiz sollte mehr mit der EU kooperieren - Wirtschaft
Germany· 2025-08-06Novartis is also under pressure from Trump to reduce their prices in the USA.
Schweiz unter Schock: Trump kündigt Zölle von 39 Prozent an - PolitikGermany· 2025-08-03
In Switzerland, ABB and Novartis are reporting this Thursday.
Anlegerstimmung nähert sich der roten ZoneSwitzerland· 2025-07-15
Novartis has not yet made any site selections for its investment program in the USA.
Roche und Novartis bewegen sich auf dünnem EisSwitzerland· 2025-07-08
Novartis is not expected to launch products with a significant impact on the market.
Novo Nordisk und Eli Lilly dominieren wohl noch JahreSwitzerland· 2025-06-25
Swiss pharma company Novartis pledged $23 billion in investments.
Brussels seeks detail on companies’ U.S. investment plans ahead of trade talks
Canada· 2025-05-27
Novartis is another Swiss company that has joined in announcing significant investments in the U.S.
Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis
France· 2025-05-14
Novartis is a pharmaceutical company that may be affected by tariffs.
Wie lange hält die Ruhe an den Börsen?Switzerland· 2025-04-14
Novartis is also expected to make efforts to optimize their US production to avoid import tariffs.
US-Zölle auf Medikamente: Schweiz drohen ProduktionsverlagerungenSwitzerland· 2025-03-22
Novartis is another company in the fund's portfolio.
«Microsoft weist eine aussergewöhnliche Vorhersehbarkeit auf»Switzerland· 2025-03-20
Novartis has experienced a stock increase of 10 percent.
Dividenden als Rendite-Booster: Ausschüttungen treiben BörsenkurseSwitzerland· 2025-03-01
